Publication:

Overview of JN.1 the variant of interest: strengths, weaknesses, opportunities, and threats analysis

Amidst the ongoing global battle against the COVID-19 pandemic, the World Health Organization (WHO) emphasizes monitoring variants of interest (VOIs) of the SARS-CoV-2 virus. The JN.1 variant, initially considered within the framework of BA.2.86, has rapidly gained global prevalence, prompting its reclassification as an independent VOI. This study assesses the strengths, weaknesses, opportunities, and threats (SWOT) analysis of the JN.1 variant. A literature review from PubMed, and expert opinions from newspaper articles were utilized for information collection. The study incorporates a comprehensive SWOT analysis, associated with the JN.1 variant. The JN.1 variant's global dominance is marked by exponential increases in COVID-19 cases, impacting healthcare systems. While strengths include global guidance, vaccine effectiveness, and a robust surveillance system, weaknesses encompass wastewater analysis, seasonal impacts, and immune escape capabilities. Opportunities lie in continuous vaccination campaigns, monitoring, research, vaccine adaptation, and adaptive strategies. Threats include co-circulation with respiratory diseases, lower antibody responses, and potential global spread. The study underscores the importance of clear public communication, continuous surveillance, and research efforts in addressing the challenges posed by the JN.1 variant. Recommendations include assessing vaccine effectiveness, updating strategies and fostering global collaboration for a more effective response.